Who
Heinz Christoph Maeusli
Director
Company insider
Files Form 4 as: Director, Lantheus Holdings; Director, Progenics Pharmaceuticals.
In numbers
- Trades disclosed
- 34
- Buys
- 8
- Sells
- 1
- Bought
- $141K
- Sold
- $1.5M
- Companies
- 2
- Companies where not an officer
- 2
- First trade
- 13 Dec 2019
- Last trade
- 14 May 2026
- Last filed
- 18 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 May 2026filed 18 May 2026 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Code A | —4,137 at $0.00 | filing |
| 14 May 2026filed 18 May 2026 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Code A | —4,137 at $0.00 | filing |
| 14 May 2025filed 16 May 2025 | LNTH Lantheus Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —4,543 at $0.00 | filing |
| 14 May 2025filed 16 May 2025 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Code A | —2,537 at $0.00 | filing |
| 28 May 2024filed 30 May 2024 | LNTH Lantheus Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code M | —17,481 at $0.00 | filing |
| 28 May 2024filed 30 May 2024 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Code M | $283K17,481 at $16.17 | filing |
| 28 May 2024filed 30 May 2024 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Sold | $5707.33 at $77.71 | filing |
| 28 May 2024filed 30 May 2024 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Sold | $972K12,307 at $78.95 | filing |
| 28 May 2024filed 30 May 2024 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Sold | $475K5,959 at $79.67 | filing |
| 28 May 2024filed 30 May 2024 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Sold | $8,029100 at $80.29 | filing |
| 9 May 2024filed 13 May 2024 | LNTH Lantheus Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —4,853 at $0.00 | filing |
| 9 May 2024filed 13 May 2024 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Code A | —2,635 at $0.00 | filing |
| 11 May 2023filed 15 May 2023 | LNTH Lantheus Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —3,798 at $0.00 | filing |
| 11 May 2023filed 15 May 2023 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Code A | —2,012 at $0.00 | filing |
| 6 May 2022filed 12 May 2022 | LNTH Lantheus Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —4,068 at $0.00 | filing |
| 6 May 2022filed 10 May 2022 | LNTH Lantheus Holdingsoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —3,616 at $0.00 | filing |
| 6 May 2022filed 10 May 2022 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Code A | —2,180 at $0.00 | filing |
| 10 May 2021filed 12 May 2021 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Code A | —8,513 at $0.00 | filing |
| 5 Mar 2021filed 9 Mar 2021 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Bought | $19K1,000 at $18.60 | filing |
| 26 Feb 2021filed 2 Mar 2021 | LNTH Lantheus HoldingsDiagnostics & Labs | SEC FORM 4 Bought | $18K1,000 at $18.02 | filing |
News
No headline names them, or the companies they trade most, lately.